Skip to content

SMARTLOAD GAB00 (REF GAB0000235)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · SMARTLOAD SENSAR 1PC CLEAR MONO 23.5D · Class 3

All models of SMARTLOAD (52)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 05050474621855), received between May 26, 2023 and Dec 22, 2025 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Contamination” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 2 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Contamination1
  • Material Opacification1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Capsular Bag Tear1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 22, 2025Material Opacification; Material Opacification

    IT WAS REPORTED THAT AFTER IMPLANTATION OF THE INTRAOCULAR LENS (IOL) IN THE PATIENT'S LEFT EYE, THE SURGEON OBSERVED A THREAD WITHIN THE LENS MATERIAL AT THE 11 O¿CLOCK POSITION, WHICH WAS NOT IDENTIFIED AS A CORTEX THREAD OR A SCRATCH, BUT A THREAD THAT IS INSIDE THE MATERIAL. THE LENS REMAINS IMPLANTED. THROUGH FOLLOW UPS, WE LEARNED THAT THE IOL WAS IMPLANTED THROUGH A COMPLETELY NORMAL PHACOEMULSIFICATION PROCEDURE. NO LENS EXCHANGE IS PLANNED. ACCOUNT INDICATED THAT THE IOL IMPLANTATION OF THE OTHER EYE (RIGHT) TOOK PLACE ON (B)(6) 2025, DURING WHICH VISUAL ACUITY OF THE LEFT EYE WAS MEASURED AS 0.8 WITH NO COMPLAINTS FROM THE PATIENT. NO FURTHER DETAILS WERE PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23874265 ↗
  • InjuryDec 19, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THERE WAS A CAPSULE RUPTURE FOLLOWING IMPLANTATION OF THE INTRAOCULAR LENS (IOL). THE LENS WAS REMOVED FROM THE EYE AND A SULCOFLEX IOL WAS IMPLANTED INSTEAD. NO FURTHER DETAILS WERE PROVIDED.

    Patient problems: Capsular Bag Tear

    MAUDE report 23855778 ↗
  • MalfunctionMay 26, 2023Contamination; Contamination

    IT WAS REPORTED THAT THE SURGEON INTRODUCED A METAL PARTICLE INTO THE PATIENT'S EYE WHEN IMPLANTING AN INTRAOCULAR LENS (IOL). THE PARTICLE WAS REMOVED AND IS AVAILABLE FOR PRODUCT INVESTIGATION. WE LEARNED THROUGH FOLLOW UP THAT THE IOL REMAINS IMPLANTED AND THAT THERE IS NO MORE INFORMATION ON HOW THE PATIENT IS DOING NOW. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17015182 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page